Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Warfarin[1] Warfarin[3] D00564 ,
D01280 ,
D08682
[2] NQO1,
VKORC1 💬
[7] Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬[13] 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97
2Warfarin 10 mg[1] Warfarin[3] D00564 ,
D01280 ,
D08682
[2] NQO1,
VKORC1 💬
[7] Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬[2] 96, 97
3Warfarin Potassium[2] Potassium,
Warfarin
[4] D00564 ,
D01280 ,
D08403 ,
D08682
[2] NQO1,
VKORC1 💬
[7] Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬[1] 88
4Warfarin Sodium[1] Warfarin[3] D00564 ,
D01280 ,
D08682
[2] NQO1,
VKORC1 💬
[7] Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬[1] 49
5Warfarin+ Vitamin K[2] Phylloquinone,
Warfarin
[4] D00148 ,
D00564 ,
D01280 ,
D08682
[2] NQO1,
VKORC1 💬
[7] Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬[1] 46
6Warm compress prior to injection of glatiramer acetate[2] Acetate,
Glatiramer
[1] D04318 [20] HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬
[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13
7Water[1] Water[1] D00001 --[23] 2, 5, 6, 13, 17, 19, 22, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299
8Water exercises[1] Water[1] D00001 --[1] 46
9WATER FOR INJECTION[1] Water[1] D00001 --[1] 35
10Water for injections[1] Water[1] D00001 --[1] 299
11WATER FOR INJECTIONS, EP[1] Water[1] D00001 --[1] 299
12WAY-130799----[1] 13
13WAY-177005----[1] 46
14WD-1603----[1] 6
15WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
16WD-1603 Carbidopa-Levodopa Extended-Release Tablets[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
17WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
18Weancare-domus----[1] 6
19Wellbutrin (bupropion)[1] Bupropion[3] D00817 ,
D07591 ,
D07938
[2] SLC6A2,
SLC6A3 💬
[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 96
20WFI----[1] 96
21Whale blubber oil----[1] 46
22Wharton Jelly Mesenchymal stem cells----[1] 97
23Wharton's jelly derived mesenchymal stem cell----[1] 90
24WHARTON’S JELLY DERIVED MESENCHYMAL STEM CELLS----[1] 36
25WHARTON’S JELLY-DERIVED MESENCHYMAL STEM CELLS----[1] 2
26Wheat[1] Wheat[1] D06902 --[3] 6, 98, 266
27Wheat bran[2] Wheat,
Wheat bran
[1] D06902 --[1] 6
28Whey protein----[2] 6, 96
29Whey Protein&Prebiotic Supplement----[1] 46
30White chocolate (0% cocoa)[1] Cocoa---[1] 6
31Whole blood sample----[1] 177
32Whole body planar SPECT imaging (15 Minutes post-injection)----[1] 46
33Whole body planar SPECT imaging (18-20 Hours post-injection)----[1] 46
34Whole body planar SPECT imaging (180 Minutes post-injection)----[1] 46
35Whole body planar SPECT imaging (60 Minutes post-injection)----[1] 46
36Whole body Protein turnover----[4] 19, 46, 96, 299
37Whole body Protein Turnover Study----[1] 299
38Whole Lung Lavage(WLL)----[1] 229
39WILATE[1] Von Willebrand factor human---[1] 288
40Wilate 1000[1] Von Willebrand factor human---[1] 288
41WILATE 1000 I.U.[1] Von Willebrand factor human---[1] 288
42WILATE 450[1] Von Willebrand factor human---[1] 288
43Wilate 500[1] Von Willebrand factor human---[1] 288
44WILATE 500 I.U.[1] Von Willebrand factor human---[1] 288
45WILATE 900[1] Von Willebrand factor human---[1] 288
46WILATE® 450[1] Von Willebrand factor human---[1] 288
47WILFACTIN----[1] 288
48Willfact----[1] 288
49Wiloctin----[1] 288
50Wilzin[1] Zinc---[1] 171
51WIN-1001X----[1] 6
52With U-VANCO (vancomycin hydrochloride)[1] Vancomycin[2] D00212 ,
D00926
--[1] 70
53Withania somnifera----[1] 2
54Without U-VANCO (vancomycin hydrochloride)[1] Vancomycin[2] D00212 ,
D00926
--[1] 70
55WJ-MSCs[1] Human Umbilical Cord Mesenchymal Stem Cells---[1] 36
56WLL----[1] 229
57WM (Shentong Granules)----[1] 66
58WMT----[1] 96
59Wound topically irrigated with 500mg TXA----[1] 70
60Wristband physical activity monitor[1] Methamidophos---[1] 13
61WTX101----[1] 171
62Wuling Powder----[1] 6
63WVE-003----[1] 8
64WVE-004----[2] 2, 127
65WVE-120101----[1] 8
66WVE-120102----[1] 8
67WVE-210201----[1] 113
68WVE-210201 (suvodirsen)----[1] 113
69WVE-N531----[1] 113